6. Pharmaceuticals, Chemicals and Electronics to Benefit | Indian exporters of pharmaceuticals, chemicals and electronics are also expected to benefit from easier access to the European market. This could help offset concerns over the EU reducing preferential access under its Generalised System of Preferences, which has already affected nearly $2 billion worth of Indian exports. (Image: Canva)
C
CNBC TV1818-02-2026, 17:07

Indian CDMO Sector Enters Multi-Year Growth Cycle: Sai Life CEO

  • Sai Life Science CEO Krishna Kanumuri states Indian CDMO sector is in early phase of a multi-year growth cycle, expected to last 5-10 years.
  • Indian CDMO companies are shifting from tactical manufacturing to strategic partnerships with global pharmaceutical firms.
  • Strategic suppliers build wider product pipelines and customer relationships for long-term stability, reducing revenue volatility.
  • The industry is in an investment phase, focusing on capacity, technology, and relationship building.
  • Global pharmaceutical supply chains are diversifying geographically due to geopolitics and risk management.

More like this

Loading more articles...